Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-04-30 4:20 pm Purchase | 13D | ALPINE IMMUNE SCIENCES INC ALPN | Decheng Capital China Life Sciences USD Fund III L.P. | 8,368,166 12.8% | 7,292 (+0.09%) | View |
| 2023-11-14 4:16 pm Purchase | 13D | ALPINE IMMUNE SCIENCES INC ALPN | Decheng Capital China Life Sciences USD Fund III L.P. | 8,360,874 14.1% | 386,667 (+4.85%) | View |
| 2022-09-27 4:00 pm Purchase | 13D | ALPINE IMMUNE SCIENCES INC ALPN | Decheng Capital China Life Sciences USD Fund III L.P. | 7,974,207 17.6% | 2,010,246 (+33.71%) | View |
| 2021-09-21 5:04 pm Purchase | 13D | ALPINE IMMUNE SCIENCES INC ALPN | Decheng Capital China Life Sciences USD Fund III L.P. | 5,963,961 19.6% | 1,554,240 (+35.25%) | View |
| 2020-12-08 4:20 pm Purchase | 13D | BEYONDSPRING INC BYSI | Decheng Capital China Life Sciences USD Fund III L.P. | 4,958,142 13% | 1,500,000 (+43.38%) | View |
| 2020-07-31 7:49 pm Purchase | 13D | ALPINE IMMUNE SCIENCES INC ALPN | Decheng Capital China Life Sciences USD Fund III L.P. | 4,409,721 17.7% | 563,132 (+14.64%) | View |
| 2020-07-27 5:19 pm Purchase | 13D | BEYONDSPRING INC BYSI | Decheng Capital China Life Sciences USD Fund III L.P. | 3,458,142 11.3% | 769,230 (+28.61%) | View |
| 2020-02-10 5:24 pm Purchase | 13G | BEYONDSPRING INC BYSI | Decheng Capital China Life Sciences USD Fund III L.P. | 2,688,912 9.7% | 1,137,172 (+73.28%) | View |
| 2019-12-23 4:07 pm Purchase | 13G | SCYNEXIS INC SCYX | Decheng Capital China Life Sciences USD Fund III L.P. | 5,555,556 5.8% | 5,555,556 (New Position) | View |
| 2019-08-02 08:01 am Purchase | 13G | BEYONDSPRING INC BYSI | Decheng Capital China Life Sciences USD Fund III L.P. | 1,551,740 6% | 1,551,740 (New Position) | View |